Europe in-vitro diagnostic services market to gain traction over 2018-2024: BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche diagnostics, Siemens, Sysmex and Thermofisher

Europe is likely to emerge as a lucrative growth ground for in-vitro diagnostic services market. According to WHO Global Health Expenditure Database, healthcare costs account for more than 10% of GDP in Europe as advancement in healthcare technology has increased the life expectancy of the average European citizen by 30 years. But it has been estimated that IVD can make significant contribution towards addressing this problem and that too at a minimal cost.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/2889

In-vitro diagnostic services market has evolved rapidly in the recent years as scientific understanding of health and well-being has drastically improved owing to the dynamic advancements in technology. For nearly half a century, there has been consistent and considerable innovation in the area of in-vitro diagnostic (IVD) as a result of which there has been remarkable increase of early recognition, diagnosis and management of disease.

According to experts in the field of IVD, the in-vitro diagnostic services market is at the threshold of an explosion in the development of diagnostic technology as knowledge of the molecular interactions increases. In-vitro diagnostic services market has gained appreciable traction as healthcare specialists have begun discovering fundamental markers of disease and predisposition to disease that have been facilitated by advanced diagnostic tests. Better diagnostic tests have led to development of more targeted therapies, further developing the scope for better healthcare facilities and increasing investments in in-vitro diagnostic services industry.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2889

With the revolution in IVD technology, tests will be able to identify an individual’s predisposition to disease, detect the presence of the disease at a molecular level, identify the best therapy for the disease and then monitor compliance of patient’s health with the therapy. Efficacy for therapy for diseases like diabetes, that have come close to assume the characteristics of a global endemic, is fundamental to the success of controlling the such diseases and developing better solutions for them. With IVD technologies being able to discern better patient compliance, it is presumed that in-vitro diagnostic services industry will attract increased attention in the sphere of healthcare.

Partial Table of Contents (ToC) of the report:
Chapter 5. In-vitro Diagnostic Services Market, By End-user
5.1. Key segment trend
5.2. Hospitals
5.2.1. Market size, by region, 2013-2024 (USD Million)
5.3. Point-of-care testing
5.3.1. Market size, by region, 2013-2024 (USD Million)
5.4. Laboratories
5.4.1. Market size, by region, 2013-2024 (USD Million)
5.5. Academic institutes
5.5.1. Market size, by region, 2013-2024 (USD Million)
5.6. Others
5.6.1. Market size, by region, 2013-2024 (USD Million)

Read More:
In-vitro Diagnostic Services Market Report 2024

http://www.digitaljournal.com/pr/3954562

In-vitro Diagnostic Services Market worth over $63 billion by 2024

https://globenewswire.com/news-release/2018/09/13/1570278/0/en/In-vitro-Diagnostic-Services-Market-worth-over-63-billion-by-2024-Global-Market-Insights-Inc.html

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: www.gminsights.com

This release was published on openPR.